Annual Accounts Payable:
$9.24M-$1.71M(-15.60%)Summary
- As of today, INBX annual accounts payable is $9.24 million, with the most recent change of -$1.71 million (-15.60%) on December 31, 2024.
- During the last 3 years, INBX annual accounts payable has risen by +$120.00 thousand (+1.32%).
- INBX annual accounts payable is now -31.30% below its all-time high of $13.46 million, reached on December 31, 2020.
Performance
INBX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Accounts Payable:
$6.77M-$1.52M(-18.32%)Summary
- As of today, INBX quarterly accounts payable is $6.77 million, with the most recent change of -$1.52 million (-18.32%) on September 30, 2025.
- Over the past year, INBX quarterly accounts payable has dropped by -$5.60 million (-45.25%).
- INBX quarterly accounts payable is now -55.40% below its all-time high of $15.19 million, reached on September 30, 2020.
Performance
INBX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
INBX Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | -15.6% | -45.3% |
| 3Y3 Years | +1.3% | -21.0% |
| 5Y5 Years | +196.8% | -55.4% |
INBX Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -15.6% | +112.9% | -54.2% | at low |
| 5Y | 5-Year | -31.3% | +196.8% | -55.4% | at low |
| All-Time | All-Time | -31.3% | +1092.9% | -55.4% | +146.0% |
INBX Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $6.77M(-18.3%) |
| Jun 2025 | - | $8.29M(-6.7%) |
| Mar 2025 | - | $8.89M(-3.8%) |
| Dec 2024 | $9.24M(-15.6%) | $9.24M(-25.3%) |
| Sep 2024 | - | $12.37M(-5.0%) |
| Jun 2024 | - | $13.02M(-12.0%) |
| Mar 2024 | - | $14.79M(+35.0%) |
| Dec 2023 | $10.95M(+152.2%) | $10.95M(+39.4%) |
| Sep 2023 | - | $7.86M(-19.0%) |
| Jun 2023 | - | $9.70M(-11.1%) |
| Mar 2023 | - | $10.92M(+31.1%) |
| Dec 2022 | $4.34M | $8.33M(-2.8%) |
| Sep 2022 | - | $8.57M(-7.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $9.25M(+17.2%) |
| Mar 2022 | - | $7.89M(-13.5%) |
| Dec 2021 | $9.13M(-32.2%) | $9.13M(-26.6%) |
| Sep 2021 | - | $12.43M(+26.0%) |
| Jun 2021 | - | $9.86M(-31.0%) |
| Mar 2021 | - | $14.29M(+6.2%) |
| Dec 2020 | $13.46M(+332.0%) | $13.46M(-11.4%) |
| Sep 2020 | - | $15.19M(+70.5%) |
| Jun 2020 | - | $8.91M(+186.0%) |
| Dec 2019 | $3.12M(-52.3%) | $3.12M(+13.1%) |
| Jun 2019 | - | $2.75M(-24.7%) |
| Mar 2019 | - | $3.66M |
| Dec 2018 | $6.53M(+742.6%) | - |
| Dec 2017 | $775.00K | - |
FAQ
- What is Inhibrx Biosciences, Inc. annual accounts payable?
- What is the all-time high annual accounts payable for Inhibrx Biosciences, Inc.?
- What is Inhibrx Biosciences, Inc. annual accounts payable year-on-year change?
- What is Inhibrx Biosciences, Inc. quarterly accounts payable?
- What is the all-time high quarterly accounts payable for Inhibrx Biosciences, Inc.?
- What is Inhibrx Biosciences, Inc. quarterly accounts payable year-on-year change?
What is Inhibrx Biosciences, Inc. annual accounts payable?
The current annual accounts payable of INBX is $9.24M
What is the all-time high annual accounts payable for Inhibrx Biosciences, Inc.?
Inhibrx Biosciences, Inc. all-time high annual accounts payable is $13.46M
What is Inhibrx Biosciences, Inc. annual accounts payable year-on-year change?
Over the past year, INBX annual accounts payable has changed by -$1.71M (-15.60%)
What is Inhibrx Biosciences, Inc. quarterly accounts payable?
The current quarterly accounts payable of INBX is $6.77M
What is the all-time high quarterly accounts payable for Inhibrx Biosciences, Inc.?
Inhibrx Biosciences, Inc. all-time high quarterly accounts payable is $15.19M
What is Inhibrx Biosciences, Inc. quarterly accounts payable year-on-year change?
Over the past year, INBX quarterly accounts payable has changed by -$5.60M (-45.25%)